glp-1 employer coverage news october 2025 Shortage = Over Patients struggle to pay for

The STEP clinical trials demonstrated mean weight losses of 14.9% to 17.4% in participants with overweight or obesity, with 69% to 79% achieving at least 10% weight loss

Before ordering, it's worth sending an email to confirm response time and to ask your pre-purchase questions - a brand that responds promptly and specifically is a meaningful signal of customer service quality

Timing considerations can vary by medication

If you are experiencing significant facial changes, skin laxity, or any concerning symptoms while on GLP-1 therapy, consult your prescribing clinician and a board-certified dermatologist or plastic surgeon for a personalized assessment

Geriatric population increasingly require therapies that offer glycemic control, weight reduction benefits, and broader cardiometabolic support